Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-25-000005

Chief Financial Officer sold 20,148 shares at $11.20 ($225,680)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cummings Keith Lamont Chief Financial Officer 2025-01-17 Sale 10b5-1 −20,148 $11.20 $225,680 262,608 D
Open-market sales · 20,148 sh · avg $11.20 · $225,680
Loading xslF345X05/wk-form4_1737587121.xml…